Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Equine eosinophilic keratoconjunctivitis in California: retrospective study of 47 eyes from 29 cases (1993-2017).
Abstract: (a) To evaluate the epidemiology of equine eosinophilic keratoconjunctivitis (EK) in the western United States, (b) to ascertain the efficacy of keratectomy and diamond burr debridement vs medical management alone, (c) to determine the efficacy of various medical therapies, and (d) to further characterize the histopathologic findings of the disease in horses. Methods: Twenty-nine horses (47 eyes) diagnosed with EK from 1993 to 2017. Methods: Retrospective medical record review; owner questionnaire. Results: Average age of presentation was 11 ± 4 years. Warmbloods were significantly overrepresented (P = 0.024). Twenty horses were treated with medical therapy alone, five were treated with superficial lamellar keratectomy, and four were treated with diamond burr debridement. Follow-up data were available for 38 eyes of 23 horses. Median time to resolution for horses treated with either superficial keratectomy or diamond burr debridement (62 days) was not statistically significantly different from those that underwent medical therapy alone (46 days; P = 0.33). Eyes treated with topical steroids had a statistically significant longer median time to resolution (61 days) compared to those that did not receive topical steroid (44 days; P = 0.023). Common histopathologic findings in keratectomy samples included the presence of eosinophils, vascularization, and an eosinophilic membrane spanning areas of ulceration. Conclusions: In this population, time to EK resolution was similar for horses treated with medical and surgical management. The use of topical steroids was associated with a prolonged time to resolution. Keratectomy samples from horses with EK had similar findings to those reported in other species.
© 2019 American College of Veterinary Ophthalmologists.
Publication Date: 2019-01-31 PubMed ID: 30706617PubMed Central: PMC6635066DOI: 10.1111/vop.12621Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Case Reports
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research evaluates the prevalence and treatment methods of equine eosinophilic keratoconjunctivitis, an eye disease in horses, in the western United States. It also examines the effectiveness of different treatments and the typical pathological features of the disease.
Research Objectives and Methods
The study aimed:
- To understand the prevalence of equine eosinophilic keratoconjunctivitis (EK), an eye disease in horses, in the western US
- To assess the effectiveness of two surgical interventions, keratectomy and diamond burr debridement, compared to solely medical treatment
- To evaluate different medical treatments for the disease
- To further explore the disease’s tissue structure and damage (histopathology) in horses.
The researchers accomplished this by a retrospective review of medical records and an owner questionnaire, referring to 29 horses diagnosed with EK from 1993 to 2017.
Findings
The study found:
- The average age of presentation was 11 ± 4 years, with Warmbloods, a breed of horse, being considerably overrepresented
- 20 horses received only medical treatment, 5 underwent a superficial lamellar keratectomy (a surgical procedure to remove pathological changes in the cornea), and 4 had diamond burr debridement (a method of removing damaged tissue or foreign objects from a wound)
- The time it took for the horses to recover from either the surgical procedures or medical treatment alone was not significantly different
- Horses treated with topical steroids had a significantly longer median time to recovery when compared to those that did not receive the steroid.
- The keratectomy samples exhibited common features like the presence of eosinophils (type of white blood cells), vascularization (the formation of new blood vessels), and an eosinophilic membrane covering areas of ulceration.
Conclusion
The study concluded that the time it took for horses to recover from EK was similar whether they underwent medical and surgical treatments. The usage of topical steroids was linked to a lengthier recovery period. The structural changes observed in the disease in horses resemble those reported in other species.
Cite This Article
APA
Knickelbein KE, Luethy D, Thomasy SM, Reilly C, Strom AR, Lassaline ME.
(2019).
Equine eosinophilic keratoconjunctivitis in California: retrospective study of 47 eyes from 29 cases (1993-2017).
Vet Ophthalmol, 22(4), 510-519.
https://doi.org/10.1111/vop.12621 Publication
Researcher Affiliations
- Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, California.
- New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania.
- Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, California.
- Department of Ophthalmology & Vision Science, School of Medicine, University of California, Davis, California.
- Insight Veterinary Specialty Pathology, Austin, Texas.
- Malmö Djursjukhus, Malmö, Sweden.
- Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, California.
MeSH Terms
- Animals
- California / epidemiology
- Debridement / veterinary
- Eosinophilia / epidemiology
- Eosinophilia / therapy
- Eosinophilia / veterinary
- Female
- Follow-Up Studies
- Horse Diseases / epidemiology
- Horse Diseases / therapy
- Horses
- Keratoconjunctivitis / epidemiology
- Keratoconjunctivitis / therapy
- Keratoconjunctivitis / veterinary
- Male
- Retrospective Studies
- Steroids / therapeutic use
Grant Funding
- K08 EY021142 / NEI NIH HHS
- K08 EY021142 / National Institutes of Health
References
This article includes 28 references
- Brooks DE, Matthews A, Clode AB. Diseases of the cornea. In: Equine Ophthalmology 3rd ed. (ed. Gilger B). John Wiley & Sons, Inc: Hoboken, NJ, USA, 2017: 252–368.
- Lassaline-Utter M, Miller C, Wotman KL. Eosinophilic keratitis in 46 eyes of 27 horses in the Mid-Atlantic United States (2008–2012). Veterinary Ophthalmology 2014;17(5):311–320.
- Grinninger P, Sanchez R, Kraijer-Huver IM, Kitslaar WJ, Schoemaker NJ, Grinwis GC, Boeve MH. Eosinophilic keratoconjunctivitis in two rabbits. Veterinary Ophthalmology 2012; 15(1): 59–65.
- Yamagata M, Wilkie DA, Gilger BC. Eosinophilic keratoconjunctivitis in seven horses. Journal of the American Veterinary Medical Association 1996; 209(7): 1283–1286.
- Dean E, Meunier V. Feline eosinophilic keratoconjunctivitis: a retrospective study of 45 cases (56 eyes). Journal of Feline Medicine and Surgery 2013; 15(8): 661–666.
- Ramsey DT, Whiteley HE, Gerding PA, Valdez RA. Eosinophilic keratoconjunctivitis in a horse. Journal of the American Veterinary Medical Association 1994; 205(9): 1308–1311.
- Jennings A. Eosinophilic keratoconjunctivitis in a donkey (abstract). British Association of Veterinary Ophthalmology Annual Conference 2007.
- Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye 2004; 18(4): 345–351.
- Trocmé SD, Kephart GM, Bourne WM, Buckley RJ, Gleich GJ. Eosinophilic granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. American Journal of Ophthalmology 1993; 155(5): 640–643.
- De Smedt S, Wildner G, Kestelyn P. Vernal keratoconjunctivitis: an update. British Journal of Ophthalmology 2012; 97(1): 9–14.
- Nasisse MP, Glover TL, Moore CP, Weigler BJ. Detection of feline herpesvirus 1 DNA in corneas of cats with eosinophilic keratitis or corneal sequestration. American Journal of Veterinary Research 1998; 59(7): 856–858.
- Edwards S, Clode AB, Gilger BC. Equine eosinophilic keratitis in horses: 28 cases (2003–2013). Clinical Case Reports 2015; 3(12): 1000–1006.
- Sandberg CA HI, Schorling JJ et al.. Ulcerative eosinophilic keratoconjunctivitis in three horses: clinical course and characterization by electron microscopy. Veterinary Ophthalmology 2008; 11(6): 413–429.
- Kafarnik C. Equine eosinophilic keratitis. Companion Animal 2010; 15(7): 4–6.
- Utter M, Cutler T, Michau T. Treatment of nonhealing ulcers in 43 horses with diamond burr debridement/keratectomy (abstract). 43rd Annual Meeting of the American College of Veterinary Ophthalmologists 2013; 16(1): E1–E21.
- Peeters LM, Janssens S, Goddeeris BM, De Keyser K, Wilson AD, Kaufmann C, Schaffartzik A, Marti E, Buys N. Evaluation of an IgE ELISA with Culicoides spp. extracts and recombinant salivary antigens for diagnosis of insect bite hypersensitivity in Warmblood horses. The Veterinary Journal 2013; 198(1): 141–147.
- Peeters LM, Janssens S, Schaffartzik A, Marti E, Buys N. Evaluation of IgE levels against Culicoides nubeculosus allergens in Belgian warmblood horses. Communications in Agricultural and Applied Biological Sciences 2012; 77(1): 218–222.
- Peeters LM, Verlinden T, Brebels M, Buys N, Janssens S. Environmental factors affecting the prevalence of insect bite hypersensitivity in Belgian warmblood horses in Vlaanderen. Communications in Agricultural and Applied Biological Sciences 2011; 76(1): 205–209.
- Marti E, Gerber H, Lazary S. On the genetic basis of equine allergic diseases: II. Insect bite dermal hypersensitivity. Equine Veteirnary Journal 1992; 24(2): 113–117.
- Spiess BM, Wilcock BP, Physick-Sheard PW. Eosinophilic granulomatous dacryoadenitis causing bilateral keratoconjunctivitis sicca in a horse. Equine Veteirnary Journal 1989; 21(3): 226–228.
- Reimer J, Latimer C. Ultrasound findings in horses with severe eyelid swelling, and recognition of acute dacryoadenitis: 10 cases (2004–2010). Veterinary Ophthalmology 2011; 14(2): 86–92.
- Andrew SE, Brooks DE, Smith PJ, Gelatt KN, Chmielewski NT, Whittaker CJG. Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1887–1996). Equine Veterinary Journal 1998; 30(2): 109–116.
- Gaarder JE, Rebhun WC, Ball MA, Patten V, Shin S, Erb H. Clinical appearances, healing patterns, risk factors, and outcomes of horses with fungal keratitis: 53 cases (1978–1996). Journal of the American Veterinary Medical Association 1998; 213(1): 105–112.
- Nussenblatt R, Palestine A. Cyclosporine: immunology, pharmacology and therapeutic uses. Survey of Ophthalmology 1986; 31(3): 159–169.
- Whitcup S, Chan C, Luyo D, Bo P, Li Q. Topical cyclosporine inhibits mast cell-mediated conjunctivitis. Investigative Ophthalmology & Visual Science 1996; 37(13): 2686–2693.
- Spiess AK, Sapienza JS, Mayordomo A. Treatment of proliferative feline eosinophilic keratitis with topical 1.5% cyclosporine: 35 cases. Veterinary Ophthalmology 2009; 12(2): 132–137.
- Prasse K, Winston S. Cytology and Histopathology of Feline Eosinophilic Keratitis. Veterinary & Comparative Ophthalmology 1996; 6(2): 74–81.
- Bentley E, Abrams GA, Covitz D, Cook CS, Fischer CA, Hacker D, Stuhr CM, Reid TW, Murphy CJ. Morphology and immunohistochemistry of spontaneous chronic corneal epithelial defects (SCCED) in dogs. Investigative Ophthalmology & Visual Science 2001; 42(10): 2262–2269.
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
